EPINEPHRINE

EPINEPHRINE was reported 66805 times

These side effects are most commonly reported by patients taking EPINEPHRINE:

# Side effect Count
0 DRUG INEFFECTIVE 6100
1 HEADACHE 4480
2 FATIGUE 4108
3 SINUSITIS 4063
4 DYSPNOEA 3536
5 NAUSEA 3435
6 PAIN 3401
7 PRODUCT DOSE OMISSION ISSUE 3270
8 OFF LABEL USE 3005
9 PNEUMONIA 2674
10 COVID-19 2642
11 COUGH 2318
12 PYREXIA 2254
13 NASOPHARYNGITIS 2216
14 RASH 2214
15 PRURITUS 2211
16 VOMITING 2063
17 DIARRHOEA 2020
18 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2015
19 DIZZINESS 1995
20 MALAISE 1966
21 URINARY TRACT INFECTION 1958
22 FALL 1949
23 URTICARIA 1911
24 PRODUCT QUALITY ISSUE 1782
25 DRUG HYPERSENSITIVITY 1780
26 ASTHMA 1767
27 WEIGHT DECREASED 1749
28 ARTHRALGIA 1696
29 ANXIETY 1674
30 HYPOTENSION 1658
31 BRONCHITIS 1641
32 ILLNESS 1594
33 ANAPHYLACTIC REACTION 1540
34 HYPERSENSITIVITY 1531
35 UPPER RESPIRATORY TRACT INFECTION 1486
36 PRODUCT USE IN UNAPPROVED INDICATION 1475
37 INFLUENZA 1437
38 CONDITION AGGRAVATED 1427
39 HEREDITARY ANGIOEDEMA 1427
40 INJECTION SITE PAIN 1416
41 INFECTION 1389
42 DEVICE FAILURE 1362
43 PAIN IN EXTREMITY 1311
44 DEATH 1284
45 WEIGHT INCREASED 1265
46 INFUSION RELATED REACTION 1225
47 BACK PAIN 1221
48 PRODUCT USE ISSUE 1203
49 ASTHENIA 1191
50 BLOOD PRESSURE INCREASED 1168
51 MIGRAINE 1092
52 HYPERTENSION 1077
53 ACCIDENTAL EXPOSURE TO PRODUCT 1065
54 CHEST PAIN 1062
55 EAR INFECTION 1038
56 ERYTHEMA 1032
57 CARDIAC ARREST 985
58 INSURANCE ISSUE 960
59 FEELING ABNORMAL 938
60 INFUSION SITE PAIN 909
61 CHEST DISCOMFORT 905
62 CHILLS 905
63 STRESS 901
64 HEART RATE INCREASED 883
65 INTENTIONAL PRODUCT USE ISSUE 876
66 RESPIRATORY TRACT INFECTION 874
67 DEPRESSION 842
68 TACHYCARDIA 827
69 ABDOMINAL PAIN 823
70 RENAL FAILURE 819
71 OROPHARYNGEAL PAIN 810
72 SEASONAL ALLERGY 799
73 PERIPHERAL SWELLING 797
74 CONTUSION 794
75 SOMNOLENCE 788
76 INSOMNIA 786
77 SWELLING 744
78 TREMOR 733
79 PALPITATIONS 720
80 WHEEZING 713
81 ABDOMINAL PAIN UPPER 710
82 UNEVALUABLE EVENT 709
83 LOSS OF CONSCIOUSNESS 706
84 MUSCLE SPASMS 700
85 ABDOMINAL DISCOMFORT 682
86 NO ADVERSE EVENT 678
87 LIQUID PRODUCT PHYSICAL ISSUE 677
88 TOXICITY TO VARIOUS AGENTS 670
89 VIRAL INFECTION 670
90 NASAL CONGESTION 669
91 INCORRECT DOSE ADMINISTERED 667
92 INFUSION SITE SWELLING 664
93 HYPOAESTHESIA 657
94 MULTIPLE ALLERGIES 639
95 SEPSIS 635
96 DEHYDRATION 629
97 INJURY 623
98 INFUSION SITE ERYTHEMA 622
99 DECREASED APPETITE 604
100 BRADYCARDIA 603
101 PRODUCTIVE COUGH 601
102 NEEDLE ISSUE 600
103 PARAESTHESIA 595
104 SEIZURE 586
105 INJECTION SITE ERYTHEMA 573
106 ANGIOEDEMA 568
107 MUSCULAR WEAKNESS 557
108 ACUTE KIDNEY INJURY 553
109 MYALGIA 547
110 CONSTIPATION 542
111 HYPERHIDROSIS 538
112 GAIT DISTURBANCE 532
113 CEREBROVASCULAR ACCIDENT 526
114 INJECTION SITE SWELLING 520
115 ATRIAL FIBRILLATION 515
116 GASTROINTESTINAL DISORDER 509
117 OVERDOSE 509
118 RHINORRHOEA 508
119 EMOTIONAL DISTRESS 501
120 ABDOMINAL DISTENSION 500
121 INFLUENZA LIKE ILLNESS 497
122 HOSPITALISATION 494
123 DYSPHAGIA 492
124 OXYGEN SATURATION DECREASED 490
125 GASTROENTERITIS VIRAL 488
126 MEMORY IMPAIRMENT 480
127 FLUSHING 476
128 BLOOD PRESSURE DECREASED 473
129 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 473
130 INFUSION SITE EXTRAVASATION 473
131 ARTHRITIS 470
132 POOR VENOUS ACCESS 467
133 MATERNAL EXPOSURE DURING PREGNANCY 466
134 SWELLING FACE 466
135 SYNCOPE 462
136 SWOLLEN TONGUE 461
137 ANAEMIA 458
138 INFUSION SITE PRURITUS 457
139 CONFUSIONAL STATE 452
140 RESPIRATORY FAILURE 447
141 CARDIAC DISORDER 445
142 DRY SKIN 445
143 FEAR 445
144 ECZEMA 441
145 PHARYNGEAL SWELLING 436
146 THROMBOSIS 428
147 RENAL IMPAIRMENT 426
148 CYSTITIS 424
149 GASTROOESOPHAGEAL REFLUX DISEASE 424
150 CELLULITIS 422
151 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 422
152 DRUG INTERACTION 421
153 MYOCARDIAL INFARCTION 416
154 FUNGAL INFECTION 415
155 VISION BLURRED 409
156 OEDEMA PERIPHERAL 407
157 STRESS CARDIOMYOPATHY 404
158 PULMONARY EMBOLISM 398
159 DERMATITIS ATOPIC 395
160 DERMATITIS CONTACT 391
161 ACCIDENTAL EXPOSURE 389
162 THROAT IRRITATION 388
163 LIP SWELLING 384
164 INFUSION SITE HAEMORRHAGE 382
165 INJECTION SITE BRUISING 382
166 SINUS DISORDER 382
167 HERPES ZOSTER 378
168 JOINT SWELLING 377
169 EXPIRED PRODUCT ADMINISTERED 375
170 NEPHROLITHIASIS 375
171 RENAL INJURY 375
172 VERTIGO 372
173 CARDIOGENIC SHOCK 370
174 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 370
175 SLEEP DISORDER 370
176 ANAPHYLACTIC SHOCK 363
177 DEVICE ISSUE 359
178 IMPAIRED QUALITY OF LIFE 358
179 NEUROPATHY PERIPHERAL 355
180 STAPHYLOCOCCAL INFECTION 353
181 THROAT TIGHTNESS 350
182 LIMB INJURY 348
183 ALOPECIA 346
184 DYSPHONIA 344
185 KIDNEY INFECTION 344
186 METABOLIC ACIDOSIS 344
187 HAEMORRHAGE 341
188 HYPOXIA 340
189 INFUSION SITE DISCHARGE 340
190 NECK PAIN 340
191 INJECTION SITE HAEMORRHAGE 339
192 DISCOMFORT 336
193 CATARACT 331
194 OEDEMA 328
195 BURNING SENSATION 325
196 INFUSION SITE BRUISING 324
197 EPISTAXIS 323
198 ANHEDONIA 322
199 INTENTIONAL OVERDOSE 320
200 FEELING HOT 319
201 PULMONARY OEDEMA 318
202 LOCALISED INFECTION 315
203 PHARYNGITIS STREPTOCOCCAL 313
204 DEVICE MALFUNCTION 311
205 INJECTION SITE PRURITUS 311
206 VISUAL IMPAIRMENT 311
207 EXPOSURE DURING PREGNANCY 310
208 THERAPY INTERRUPTED 305
209 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 298
210 BALANCE DISORDER 296
211 DRUG DOSE OMISSION 296
212 TOOTH INFECTION 294
213 VENTRICULAR TACHYCARDIA 287
214 SKIN EXFOLIATION 286
215 RASH PRURITIC 284
216 SHOCK 281
217 DYSPEPSIA 280
218 CHRONIC KIDNEY DISEASE 279
219 DEEP VEIN THROMBOSIS 279
220 INCORRECT DRUG ADMINISTRATION RATE 279
221 INJECTION SITE REACTION 279
222 HAEMOGLOBIN DECREASED 278
223 RESPIRATORY DISORDER 278
224 MULTI-ORGAN FAILURE 275
225 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 275
226 DYSPNOEA EXERTIONAL 274
227 LACTIC ACIDOSIS 273
228 PRODUCT DISTRIBUTION ISSUE 272
229 THERAPY NON-RESPONDER 271
230 SURGERY 268
231 DRY EYE 267
232 PRODUCT DOSE OMISSION IN ERROR 266
233 RESPIRATORY DISTRESS 264
234 EYE SWELLING 262
235 BLOOD GLUCOSE INCREASED 261
236 FOOD ALLERGY 261
237 SKIN INFECTION 259
238 INJURY ASSOCIATED WITH DEVICE 257
239 ADVERSE DRUG REACTION 256
240 LUNG DISORDER 256
241 HEAD INJURY 253
242 HEART RATE DECREASED 253
243 LOWER RESPIRATORY TRACT INFECTION 252
244 THERAPEUTIC RESPONSE DECREASED 252
245 LETHARGY 251
246 MUSCULOSKELETAL STIFFNESS 251
247 TINNITUS 250
248 EYE INFECTION 248
249 RHEUMATOID ARTHRITIS 248
250 CARDIAC FAILURE CONGESTIVE 245
251 ROAD TRAFFIC ACCIDENT 244
252 WEIGHT FLUCTUATION 243
253 POST PROCEDURAL COMPLICATION 239
254 RESPIRATORY TRACT CONGESTION 239
255 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 239
256 MEDICATION ERROR 236
257 RHINITIS 235
258 DIABETES MELLITUS 234
259 BACTERIAL INFECTION 233
260 DIVERTICULITIS 233
261 DRY MOUTH 232
262 SPEECH DISORDER 231
263 ACCIDENTAL OVERDOSE 230
264 SEPTIC SHOCK 228
265 SKIN DISCOLOURATION 227
266 ARRHYTHMIA 226
267 RASH ERYTHEMATOUS 226
268 CARDIO-RESPIRATORY ARREST 224
269 EYE PRURITUS 224
270 COMA 221
271 CANDIDA INFECTION 220
272 THROMBOCYTOPENIA 220
273 FLUID RETENTION 219
274 SINUS CONGESTION 219
275 SKIN LACERATION 218
276 GENERAL PHYSICAL HEALTH DETERIORATION 217
277 PLEURAL EFFUSION 217
278 BLOOD PRESSURE ABNORMAL 216
279 BRAIN FOG 214
280 AGITATION 212
281 MULTIPLE ORGAN DYSFUNCTION SYNDROME 209
282 EYE IRRITATION 207
283 BLISTER 206
284 DRUG INTOLERANCE 206
285 JOINT INJURY 206
286 LYMPHADENOPATHY 205
287 DRUG DOSE OMISSION BY DEVICE 203
288 EYE PAIN 203
289 SYSTEMIC LUPUS ERYTHEMATOSUS 203
290 HOT FLUSH 201
291 HAEMATOCHEZIA 200
292 NERVOUSNESS 199
293 OCULAR HYPERAEMIA 199
294 PLATELET COUNT DECREASED 199
295 VENTRICULAR FIBRILLATION 199
296 SINUS TACHYCARDIA 198
297 UNDERDOSE 197
298 ELECTROCARDIOGRAM QT PROLONGED 196
299 SNEEZING 194
300 CARDIAC FAILURE 193
301 RASH MACULAR 192
302 FOOT FRACTURE 191
303 PHARYNGITIS 191
304 LACRIMATION INCREASED 190
305 BRONCHOSPASM 189
306 ACUTE MYOCARDIAL INFARCTION 186
307 OSTEOPOROSIS 186
308 EAR PAIN 185
309 HYPOKALAEMIA 184
310 PHARYNGEAL OEDEMA 184
311 PSORIASIS 184
312 DEVICE USE ISSUE 182
313 FOETAL EXPOSURE DURING PREGNANCY 182
314 UNRESPONSIVE TO STIMULI 182
315 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 181
316 DYSGEUSIA 179
317 GASTROINTESTINAL INFECTION 179
318 PALLOR 179
319 PANIC ATTACK 179
320 BLOOD POTASSIUM DECREASED 178
321 BONE PAIN 178
322 DEPRESSED MOOD 178
323 GASTROINTESTINAL HAEMORRHAGE 178
324 WHITE BLOOD CELL COUNT DECREASED 178
325 INTENTIONAL DOSE OMISSION 176
326 RECTAL HAEMORRHAGE 176
327 HEPATIC ENZYME INCREASED 175
328 NEOPLASM MALIGNANT 175
329 SUICIDAL IDEATION 175
330 INFUSION SITE MASS 174
331 BLOOD CREATININE INCREASED 173
332 PRODUCT STORAGE ERROR 173
333 WHITE BLOOD CELL COUNT INCREASED 172
334 LIMB DISCOMFORT 171
335 INTENTIONAL PRODUCT MISUSE 170
336 MOBILITY DECREASED 170
337 DEVICE RELATED INFECTION 169
338 SCAR 169
339 CLOSTRIDIUM DIFFICILE INFECTION 167
340 CONJUNCTIVITIS 167
341 FEELING COLD 167
342 FIBROMYALGIA 167
343 ILL-DEFINED DISORDER 167
344 SLEEP APNOEA SYNDROME 167
345 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 166
346 RENAL DISORDER 166
347 RESPIRATORY SYNCYTIAL VIRUS INFECTION 166
348 TENDERNESS 165
349 DEPRESSED LEVEL OF CONSCIOUSNESS 164
350 PANCREATITIS 164
351 PARAESTHESIA ORAL 163
352 BLOOD PRESSURE SYSTOLIC INCREASED 161
353 CIRCULATORY COLLAPSE 161
354 INFLAMMATION 161
355 MENTAL DISORDER 160
356 PROCEDURAL PAIN 160
357 TOOTH ABSCESS 160
358 BODY TEMPERATURE INCREASED 159
359 PRODUCT AVAILABILITY ISSUE 159
360 UPPER-AIRWAY COUGH SYNDROME 159
361 COVID-19 PNEUMONIA 158
362 EXPIRED DRUG ADMINISTERED 158
363 COLITIS ULCERATIVE 157
364 HAEMODYNAMIC INSTABILITY 157
365 NEURALGIA 157
366 ORAL HERPES 157
367 THERAPEUTIC RESPONSE SHORTENED 157
368 ACUTE RESPIRATORY DISTRESS SYNDROME 156
369 RENAL FAILURE ACUTE 156
370 DYSARTHRIA 154
371 DEVICE LEAKAGE 153
372 DYSURIA 152
373 BLOOD PRESSURE FLUCTUATION 151
374 NEUTROPENIA 151
375 TREATMENT FAILURE 151
376 ARTHROPATHY 150
377 PRODUCT COLOUR ISSUE 150
378 PULSELESS ELECTRICAL ACTIVITY 150
379 COLITIS 149
380 HYPERSOMNIA 148
381 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 148
382 OSTEOARTHRITIS 148
383 ARTHROPOD BITE 147
384 BRONCHIECTASIS 147
385 INFUSION SITE RASH 146
386 LIGAMENT SPRAIN 146
387 RIB FRACTURE 146
388 DEVICE INFUSION ISSUE 144
389 WOUND 144
390 STOMATITIS 143
391 THERAPEUTIC RESPONSE UNEXPECTED 143
392 AMNESIA 142
393 INFUSION SITE REACTION 142
394 OBSTRUCTIVE AIRWAYS DISORDER 142
395 OBSTRUCTION 140
396 PRODUCT ADMINISTRATION INTERRUPTED 140
397 ACUTE RESPIRATORY FAILURE 139
398 KOUNIS SYNDROME 139
399 MUSCULOSKELETAL DISCOMFORT 139
400 IRRITABILITY 138
401 NIGHTMARE 138
402 STREPTOCOCCAL INFECTION 138
403 TREATMENT NONCOMPLIANCE 138
404 FEBRILE NEUTROPENIA 137
405 MIDDLE INSOMNIA 137
406 THERAPEUTIC PRODUCT EFFECT DECREASED 137
407 TRANSIENT ISCHAEMIC ATTACK 137
408 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 136
409 DISTURBANCE IN ATTENTION 136
410 MENTAL STATUS CHANGES 136
411 POOR QUALITY SLEEP 136
412 INTESTINAL OBSTRUCTION 135
413 ARTERIOSPASM CORONARY 134
414 CARDIAC MURMUR 134
415 CHRONIC SINUSITIS 134
416 MUSCULOSKELETAL PAIN 134
417 DISEASE PROGRESSION 133
418 INJECTION SITE RASH 133
419 PNEUMONIA ASPIRATION 133
420 PREMATURE BABY 133
421 FREQUENT BOWEL MOVEMENTS 132
422 SKIN DISORDER 132
423 HAEMOPTYSIS 131
424 HYPERKALAEMIA 131
425 COGNITIVE DISORDER 130
426 FEELING JITTERY 130
427 INJECTION SITE MASS 130
428 BLOOD GLUCOSE DECREASED 129
429 INJECTION SITE URTICARIA 129
430 PSEUDOMONAS INFECTION 128
431 SUICIDE ATTEMPT 128
432 HERNIA 127
433 HIP FRACTURE 127
434 INJECTION SITE PALLOR 127
435 IMPAIRED WORK ABILITY 126
436 CYANOSIS 125
437 PNEUMOTHORAX 125
438 INJECTION SITE DISCOLOURATION 124
439 INTERVERTEBRAL DISC PROTRUSION 124
440 NERVOUS SYSTEM DISORDER 124
441 RED BLOOD CELL COUNT DECREASED 124
442 RHABDOMYOLYSIS 124
443 HAEMATOMA 122
444 POLLAKIURIA 122
445 ANKLE FRACTURE 121
446 EYE DISORDER 121
447 SKIN BURNING SENSATION 121
448 PRESYNCOPE 120
449 ALANINE AMINOTRANSFERASE INCREASED 119
450 POST PROCEDURAL INFECTION 118
451 PRODUCT PRESCRIBING ISSUE 118
452 PULMONARY HYPERTENSION 118
453 INCORRECT ROUTE OF DRUG ADMINISTRATION 117
454 BACK DISORDER 116
455 ORAL CANDIDIASIS 116
456 APHONIA 115
457 DIPLOPIA 115
458 GENERALISED TONIC-CLONIC SEIZURE 115
459 HEART RATE IRREGULAR 115
460 MYOCARDIAL ISCHAEMIA 115
461 PULMONARY MASS 115
462 SKIN CANCER 115
463 UPPER LIMB FRACTURE 115
464 CONCUSSION 114
465 HYPOGLYCAEMIA 114
466 NIGHT SWEATS 114
467 ASPARTATE AMINOTRANSFERASE INCREASED 113
468 INJECTION SITE INJURY 113
469 LARYNGITIS 113
470 MYASTHENIA GRAVIS 113
471 SCRATCH 113
472 ACNE 112
473 OSTEOMYELITIS 112
474 COAGULOPATHY 111
475 CRYING 111
476 HYPOAESTHESIA ORAL 111
477 HYPOPNOEA 111
478 PAROSMIA 111
479 SKIN ABRASION 111
480 IMPAIRED GASTRIC EMPTYING 110
481 PAIN IN JAW 110
482 SARS-COV-2 TEST POSITIVE 110
483 VITAMIN D DEFICIENCY 110
484 PRODUCT ADMINISTRATION ERROR 109
485 SKIN IRRITATION 109
486 ULCER 109
487 ADVERSE EVENT 108
488 PRESCRIBED OVERDOSE 108
489 PRODUCT DOSE OMISSION 108
490 SKIN LESION 108
491 WRIST FRACTURE 108
492 BREAST CANCER 107
493 CARPAL TUNNEL SYNDROME 107
494 GASTRITIS 107
495 ELECTROCARDIOGRAM ABNORMAL 106
496 DEVICE BREAKAGE 105
497 EATING DISORDER 105
498 MUSCLE TIGHTNESS 105
499 MUSCULOSKELETAL CHEST PAIN 105
500 PREGNANCY 105
501 TYPE 2 DIABETES MELLITUS 105
502 SKIN FISSURES 104
503 FLATULENCE 103
504 LUNG INFECTION 103
505 PARALYSIS 103
506 TUBULOINTERSTITIAL NEPHRITIS 103
507 BLOOD SODIUM DECREASED 102
508 FOOD POISONING 102
509 SECRETION DISCHARGE 102
510 WOUND INFECTION 102
511 BLINDNESS 101
512 BLOOD CHOLESTEROL INCREASED 101
513 EJECTION FRACTION DECREASED 101
514 FEEDING DISORDER 101
515 SUPRAVENTRICULAR TACHYCARDIA 101
516 TOOTH DISORDER 101
517 DRUG EFFECT INCOMPLETE 100
518 HEAD DISCOMFORT 100
519 HYPERGLYCAEMIA 100
520 PRE-EXISTING CONDITION IMPROVED 100
521 PREMATURE DELIVERY 100
522 CHOLELITHIASIS 99
523 GAIT INABILITY 99
524 INFUSION SITE DISCOMFORT 99
525 PARANASAL SINUS DISCOMFORT 99
526 VASCULAR ACCESS SITE COMPLICATION 99
527 DEVICE OCCLUSION 98
528 PERICARDIAL EFFUSION 98
529 PNEUMONIA BACTERIAL 98
530 VENTRICULAR EXTRASYSTOLES 98
531 BRAIN INJURY 97
532 INABILITY TO AFFORD MEDICATION 97
533 LOWER LIMB FRACTURE 97
534 PERIPHERAL ISCHAEMIA 97
535 SPINAL FRACTURE 97
536 TOXIC ANTERIOR SEGMENT SYNDROME 97
537 VASOPLEGIA SYNDROME 97
538 COMPLICATION ASSOCIATED WITH DEVICE 96
539 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 96
540 OROPHARYNGEAL DISCOMFORT 96
541 SENSITIVE SKIN 96
542 BLOOD LACTIC ACID INCREASED 95
543 DISORIENTATION 95
544 VASCULAR DEVICE INFECTION 95
545 GINGIVAL PAIN 94
546 SPINAL OPERATION 94
547 APLASTIC ANAEMIA 93
548 CARDIOMYOPATHY 93
549 DRUG ADMINISTRATION ERROR 93
550 HEPATIC FAILURE 93
551 INFUSION SITE URTICARIA 93
552 IRRITABLE BOWEL SYNDROME 93
553 LARYNGEAL OEDEMA 93
554 MASS 93
555 MULTIPLE SCLEROSIS 93
556 RASH PAPULAR 93
557 URINARY RETENTION 93
558 CARDIOTOXICITY 92
559 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 92
560 HYPOPHAGIA 92
561 TACHYPNOEA 92
562 BODY HEIGHT DECREASED 91
563 IMPAIRED HEALING 91
564 POST-TRAUMATIC STRESS DISORDER 91
565 RESPIRATORY DEPRESSION 91
566 TOOTHACHE 91
567 CENTRAL VENOUS CATHETERISATION 90
568 COLD SWEAT 90
569 EXPOSURE VIA SKIN CONTACT 90
570 HALLUCINATION 90
571 SPUTUM DISCOLOURED 90
572 APHASIA 89
573 C-REACTIVE PROTEIN INCREASED 89
574 CHOKING 89
575 CROHN^S DISEASE 89
576 MAST CELL ACTIVATION SYNDROME 89
577 MENINGITIS ASEPTIC 89
578 MUSCLE STRAIN 89
579 PULMONARY CONGESTION 89
580 RESPIRATORY ARREST 89
581 ROTATOR CUFF SYNDROME 88
582 SINUS BRADYCARDIA 88
583 TEMPERATURE INTOLERANCE 88
584 ATELECTASIS 87
585 AUTOIMMUNE DISORDER 87
586 BLOOD PRESSURE DIASTOLIC DECREASED 87
587 BLOOD UREA INCREASED 87
588 BURNS SECOND DEGREE 87
589 ADMINISTRATION SITE PAIN 86
590 INCORRECT PRODUCT ADMINISTRATION DURATION 86
591 INFUSION SITE NODULE 86
592 MYDRIASIS 86
593 RESTLESS LEGS SYNDROME 86
594 ACIDOSIS 85
595 BRAIN OEDEMA 85
596 CEREBRAL HAEMORRHAGE 85
597 CONVULSION 85
598 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 85
599 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 85
600 EMOTIONAL DISORDER 84
601 GALLBLADDER DISORDER 84
602 HYPOACUSIS 84
603 INFUSION SITE IRRITATION 84
604 KNEE ARTHROPLASTY 84
605 DYSKINESIA 83
606 FLANK PAIN 83
607 HAND FRACTURE 83
608 DERMATITIS 82
609 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 82
610 LIVER DISORDER 82
611 PRODUCT USE COMPLAINT 82
612 RESTLESSNESS 82
613 THYROID DISORDER 82
614 ABSCESS 81
615 ADRENAL INSUFFICIENCY 81
616 DELIRIUM 81
617 HAEMATEMESIS 81
618 HIATUS HERNIA 81
619 HORDEOLUM 81
620 HYPONATRAEMIA 81
621 INJECTION SITE HYPOAESTHESIA 81
622 RETCHING 81
623 RHINOVIRUS INFECTION 81
624 DISSEMINATED INTRAVASCULAR COAGULATION 80
625 EMPHYSEMA 80
626 ESCHERICHIA INFECTION 80
627 RESPIRATORY ACIDOSIS 80
628 AGGRESSION 79
629 CATARRH 79
630 ENCEPHALOPATHY 79
631 HAEMORRHOIDS 79
632 LEUKOCYTOSIS 79
633 PHOTOPHOBIA 79
634 PSORIATIC ARTHROPATHY 79
635 PULSE ABSENT 79
636 SEROTONIN SYNDROME 79
637 STEROID DEPENDENCE 79
638 DISABILITY 78
639 DISTRIBUTIVE SHOCK 78
640 GASTRIC DISORDER 78
641 HYPOTHYROIDISM 78
642 URINARY INCONTINENCE 78
643 ANAESTHETIC COMPLICATION 77
644 ARTHROPOD STING 77
645 MOUTH SWELLING 77
646 OBESITY 77
647 PULMONARY THROMBOSIS 77
648 SKIN HAEMORRHAGE 77
649 THERMAL BURN 77
650 BODY TEMPERATURE DECREASED 76
651 DECREASED ACTIVITY 76
652 FEMUR FRACTURE 76
653 LIVE BIRTH 76
654 MITRAL VALVE INCOMPETENCE 76
655 TROPONIN INCREASED 76
656 ANIMAL BITE 75
657 HEPATIC STEATOSIS 75
658 MATERNAL EXPOSURE DURING DELIVERY 75
659 RHINITIS ALLERGIC 75
660 ABNORMAL BEHAVIOUR 74
661 CYST 74
662 EXTRA DOSE ADMINISTERED 74
663 MULTIPLE SCLEROSIS RELAPSE 74
664 TOOTH FRACTURE 74
665 BLOOD IRON DECREASED 73
666 CATHETER SITE PAIN 73
667 CORONARY ARTERY DISEASE 73
668 HAEMATOCRIT DECREASED 73
669 INFUSION SITE WARMTH 73
670 INJECTION SITE EXTRAVASATION 73
671 ORAL PAIN 73
672 RESPIRATORY RATE INCREASED 73
673 DEVICE DIFFICULT TO USE 72
674 EYELID PTOSIS 72
675 GOUT 72
676 LEFT VENTRICULAR DYSFUNCTION 72
677 LYME DISEASE 72
678 SKIN ULCER 72
679 SPINAL DISORDER 72
680 THERAPY CESSATION 72
681 ANGER 71
682 BLOOD URINE PRESENT 71
683 DRUG EFFECT DECREASED 71
684 ECONOMIC PROBLEM 71
685 FACIAL PAIN 71
686 MOVEMENT DISORDER 71
687 PANCYTOPENIA 71
688 RALES 71
689 ASPIRATION 70
690 BACTERAEMIA 70
691 FACIAL PARALYSIS 70
692 HYPERAESTHESIA 70
693 NASAL DISCOMFORT 70
694 STRIDOR 70
695 VISUAL ACUITY REDUCED 70
696 EAR DISCOMFORT 69
697 HYPERLACTACIDAEMIA 69
698 INJECTION SITE WARMTH 69
699 JOINT STIFFNESS 69
700 NERVE COMPRESSION 69
701 PHOTOSENSITIVITY REACTION 69
702 SCIATICA 69
703 DEVICE DEFECTIVE 68
704 IMMUNE SYSTEM DISORDER 68
705 INJECTION SITE LACERATION 68
706 PRODUCT SUBSTITUTION ISSUE 68
707 CHROMATURIA 67
708 GLAUCOMA 67
709 HYPERLIPIDAEMIA 67
710 ABORTION SPONTANEOUS 66
711 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 66
712 ENDOPHTHALMITIS 66
713 PERIPHERAL COLDNESS 66
714 RESPIRATORY TRACT INFECTION VIRAL 66
715 SCAB 66
716 WRONG TECHNIQUE IN DRUG USAGE PROCESS 66
717 BLOOD ALKALINE PHOSPHATASE INCREASED 65
718 BURSITIS 65
719 GASTRIC INFECTION 65
720 INJECTION SITE HAEMATOMA 65
721 PRURITUS GENERALISED 65
722 PULMONARY HAEMORRHAGE 65
723 VENTRICULAR HYPOKINESIA 65
724 ANURIA 64
725 BACK INJURY 64
726 DRUG EFFECT LESS THAN EXPECTED 64
727 END STAGE RENAL DISEASE 64
728 FULL BLOOD COUNT ABNORMAL 64
729 HYPOKINESIA 64
730 ISCHAEMIA 64
731 LABORATORY TEST ABNORMAL 64
732 POST PROCEDURAL HAEMORRHAGE 64
733 POSTOPERATIVE WOUND INFECTION 64
734 SUSPECTED COVID-19 64
735 VEIN DISORDER 64
736 DEAFNESS 63
737 EYE INFLAMMATION 63
738 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 63
739 INJECTION SITE DISCOMFORT 63
740 RESPIRATION ABNORMAL 63
741 ANGINA PECTORIS 62
742 HEART RATE ABNORMAL 62
743 HYPERVOLAEMIA 62
744 INJECTION SITE COLDNESS 62
745 LOW BIRTH WEIGHT BABY 62
746 PHARMACEUTICAL PRODUCT COMPLAINT 62
747 PNEUMONITIS 62
748 PRODUCT PREPARATION ERROR 62
749 VENTRICULAR ARRHYTHMIA 62
750 VITAMIN D DECREASED 62
751 ADMINISTRATION SITE SWELLING 61
752 APNOEA 61
753 ATRIAL FLUTTER 61
754 CARDIOMEGALY 61
755 FACE OEDEMA 61
756 ORAL INFECTION 61
757 OXYGEN SATURATION ABNORMAL 61
758 QUALITY OF LIFE DECREASED 61
759 SEDATION 61
760 ASCITES 60
761 BLOOD PRESSURE SYSTOLIC DECREASED 60
762 GENERALISED OEDEMA 60
763 GLYCOSYLATED HAEMOGLOBIN INCREASED 60
764 HYPERCAPNIA 60
765 LYMPHOMA 60
766 NO DEVICE MALFUNCTION 60
767 OCULAR DISCOMFORT 60
768 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 60
769 SINUS HEADACHE 60
770 TOOTH EXTRACTION 60
771 WRONG DRUG ADMINISTERED 60
772 ABDOMINAL PAIN LOWER 59
773 ARTHRITIS INFECTIVE 59
774 DYSSTASIA 59
775 IMMUNODEFICIENCY 59
776 INTERVERTEBRAL DISC DEGENERATION 59
777 MENTAL IMPAIRMENT 59
778 MUSCLE TWITCHING 59
779 URINE OUTPUT DECREASED 59
780 VITAMIN B12 DEFICIENCY 59
781 COORDINATION ABNORMAL 58
782 DECUBITUS ULCER 58
783 HAEMATURIA 58
784 JOINT DISLOCATION 58
785 MALIGNANT NEOPLASM PROGRESSION 58
786 NERVE INJURY 58
787 NEUTROPHIL COUNT INCREASED 58
788 SENSITIVITY TO WEATHER CHANGE 58
789 SMALL INTESTINAL OBSTRUCTION 58
790 TASTE DISORDER 58
791 THIRST 58
792 BASAL CELL CARCINOMA 57
793 BLADDER DISORDER 57
794 BODY TEMPERATURE ABNORMAL 57
795 BREATH SOUNDS ABNORMAL 57
796 PARANASAL SINUS HYPERSECRETION 57
797 RASH GENERALISED 57
798 SKELETAL INJURY 57
799 STATUS EPILEPTICUS 57
800 TORSADE DE POINTES 57
801 DEVICE DISLOCATION 56
802 GASTRIC ULCER 56
803 NODULE 56
804 NORMAL NEWBORN 56
805 PRODUCT COMPLAINT 56
806 RENAL TUBULAR NECROSIS 56
807 SJOGREN^S SYNDROME 56
808 BIPOLAR DISORDER 55
809 BLOOD BILIRUBIN INCREASED 55
810 BLOOD POTASSIUM INCREASED 55
811 FORCED EXPIRATORY VOLUME DECREASED 55
812 INFUSION SITE INDURATION 55
813 LAGOPHTHALMOS 55
814 PAIN OF SKIN 55
815 RED BLOOD CELL SEDIMENTATION RATE INCREASED 55
816 BLOOD CREATINE PHOSPHOKINASE INCREASED 54
817 COMPARTMENT SYNDROME 54
818 HYPOTHERMIA 54
819 INJECTION SITE DISCHARGE 54
820 INJECTION SITE IRRITATION 54
821 KNEE OPERATION 54
822 LEUKOPENIA 54
823 VEIN RUPTURE 54
824 ACUTE PULMONARY OEDEMA 53
825 ATRIOVENTRICULAR BLOCK 53
826 DEVICE DELIVERY SYSTEM ISSUE 53
827 FAECES DISCOLOURED 53
828 HEMIPARESIS 53
829 HYSTERECTOMY 53
830 MOOD ALTERED 53
831 PERIORBITAL SWELLING 53
832 SENSATION OF FOREIGN BODY 53
833 SKIN REACTION 53
834 SYRINGE ISSUE 53
835 ACCIDENT 52
836 BLOOD IMMUNOGLOBULIN E INCREASED 52
837 ELECTROLYTE IMBALANCE 52
838 EYE DISCHARGE 52
839 LOCAL SWELLING 52
840 NEPHROGENIC ANAEMIA 52
841 NEUTROPHIL COUNT DECREASED 52
842 NOROVIRUS INFECTION 52
843 ACUTE CORONARY SYNDROME 51
844 ALLERGIC SINUSITIS 51
845 BLOOD TEST ABNORMAL 51
846 EOSINOPHIL COUNT INCREASED 51
847 EYELID OEDEMA 51
848 GINGIVITIS 51
849 INFUSION SITE DISCOLOURATION 51
850 INFUSION SITE SCAR 51
851 PLEURISY 51
852 PSYCHOTIC DISORDER 51
853 BLOOD IMMUNOGLOBULIN G DECREASED 50
854 EAR DISORDER 50
855 HEPARIN-INDUCED THROMBOCYTOPENIA 50
856 HYPERTENSIVE CRISIS 50
857 INTESTINAL ISCHAEMIA 50
858 IRON DEFICIENCY ANAEMIA 50
859 LYMPHOCYTE COUNT DECREASED 50
860 MENINGITIS 50
861 MUCOSAL INFLAMMATION 50
862 NASAL DISCHARGE DISCOLOURATION 50
863 NASAL POLYPS 50
864 OSTEOPENIA 50
865 SKIN SWELLING 50
866 BLOOD MAGNESIUM DECREASED 49
867 CHOLECYSTECTOMY 49
868 COMPLETED SUICIDE 49
869 DERMATITIS ALLERGIC 49
870 FLUID OVERLOAD 49
871 FURUNCLE 49
872 INTERSTITIAL LUNG DISEASE 49
873 PRODUCT PACKAGING CONFUSION 49
874 SUSPECTED OFF LABEL USE 49
875 TENDONITIS 49
876 ATYPICAL PNEUMONIA 48
877 BLOOD CALCIUM DECREASED 48
878 FEAR OF INJECTION 48
879 INTRAOCULAR PRESSURE INCREASED 48
880 MIDDLE EAR EFFUSION 48
881 NEOPLASM 48
882 NEUROTOXICITY 48
883 ORAL PRURITUS 48
884 PRODUCT PACKAGING ISSUE 48
885 THERAPY CHANGE 48
886 ASPERGILLUS INFECTION 47
887 BONE DISORDER 47
888 GASTROENTERITIS 47
889 IMMUNISATION REACTION 47
890 INJECTION SITE INDURATION 47
891 LIVER FUNCTION TEST ABNORMAL 47
892 PRODUCT LABEL ISSUE 47
893 PRODUCT PREPARATION ISSUE 47
894 THROAT CLEARING 47
895 VAGINAL HAEMORRHAGE 47
896 WRONG PRODUCT ADMINISTERED 47
897 ALTERED STATE OF CONSCIOUSNESS 46
898 BLOOD GLUCOSE ABNORMAL 46
899 DEMENTIA 46
900 DRUG ABUSE 46
901 EXTREMITY NECROSIS 46
902 FULL BLOOD COUNT DECREASED 46
903 HORNER^S SYNDROME 46
904 MOOD SWINGS 46
905 PRODUCT DISPENSING ERROR 46
906 RESTRICTIVE PULMONARY DISEASE 46
907 RIGHT VENTRICULAR FAILURE 46
908 VASOCONSTRICTION 46
909 ADVERSE REACTION 45
910 ANAL INCONTINENCE 45
911 CATHETERISATION CARDIAC 45
912 CORNEAL OEDEMA 45
913 FRACTURE 45
914 GASTROINTESTINAL PAIN 45
915 INCORRECT DOSE ADMINISTERED BY DEVICE 45
916 INCREASED APPETITE 45
917 INFECTED BITE 45
918 INFUSION SITE INFECTION 45
919 INFUSION SITE OEDEMA 45
920 INTERNATIONAL NORMALISED RATIO INCREASED 45
921 MIOSIS 45
922 MOUTH ULCERATION 45
923 PELVIC PAIN 45
924 PROCEDURAL COMPLICATION 45
925 PSYCHOMOTOR HYPERACTIVITY 45
926 SCOLIOSIS 45
927 SINUSITIS BACTERIAL 45
928 SKIN NECROSIS 45
929 SNORING 45
930 SWELLING OF EYELID 45
931 BLOOD TRIGLYCERIDES INCREASED 44
932 DRUG WITHDRAWAL SYNDROME 44
933 EXOSTOSIS 44
934 HAEMATOLOGICAL INFECTION 44
935 HIP ARTHROPLASTY 44
936 INJECTION SITE ANAESTHESIA 44
937 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 44
938 LACERATION 44
939 PANCREATITIS ACUTE 44
940 PRODUCT PRESCRIBING ERROR 44
941 PULMONARY FIBROSIS 44
942 TRICUSPID VALVE INCOMPETENCE 44
943 ALCOHOL POISONING 43
944 CYTOKINE RELEASE SYNDROME 43
945 GANGRENE 43
946 HYPOVOLAEMIA 43
947 LUNG NEOPLASM MALIGNANT 43
948 OSTEONECROSIS 43
949 PLASMA CELL MYELOMA 43
950 RUBBER SENSITIVITY 43
951 TRYPTASE INCREASED 43
952 ABNORMAL DREAMS 42
953 ATRIOVENTRICULAR BLOCK COMPLETE 42
954 DISEASE RECURRENCE 42
955 DRUG DEPENDENCE 42
956 HEPATOMEGALY 42
957 INJECTION SITE SCAR 42
958 LEUKAEMIA 42
959 LIGAMENT RUPTURE 42
960 LYMPHOEDEMA 42
961 PELVIC FRACTURE 42
962 SENSORY DISTURBANCE 42
963 SLUGGISHNESS 42
964 UPPER GASTROINTESTINAL HAEMORRHAGE 42
965 DENTAL CARIES 41
966 IMMUNOGLOBULINS DECREASED 41
967 INCREASED TENDENCY TO BRUISE 41
968 LIVER FUNCTION TEST INCREASED 41
969 MACULAR DEGENERATION 41
970 MONOCYTE COUNT INCREASED 41
971 POST-ACUTE COVID-19 SYNDROME 41
972 PRODUCT LABEL CONFUSION 41
973 SENSORY LOSS 41
974 TENDON RUPTURE 41
975 TRANSFUSION 41
976 VIRAL UPPER RESPIRATORY TRACT INFECTION 41
977 VITREOUS FLOATERS 41
978 ALLERGY TO PLANTS 40
979 ATTENTION DEFICIT HYPERACTIVITY DISORDER 40
980 AUTOIMMUNE THYROIDITIS 40
981 CARDIOVASCULAR DISORDER 40
982 CHOLECYSTITIS ACUTE 40
983 EPSTEIN-BARR VIRUS INFECTION 40
984 HEPATIC CIRRHOSIS 40
985 HEPATITIS 40
986 INCONTINENCE 40
987 ORAL DISCOMFORT 40
988 PERIORBITAL OEDEMA 40
989 PNEUMONIA VIRAL 40
990 PYELONEPHRITIS 40
991 SINUS PAIN 40
992 SKIN WARM 40
993 AGEUSIA 39
994 ALLERGY TO ANIMAL 39
995 BLOOD LACTATE DEHYDROGENASE INCREASED 39
996 BRASH SYNDROME 39
997 CEREBRAL INFARCTION 39
998 COAGULATION FACTOR DEFICIENCY 39
999 DIABETIC KETOACIDOSIS 39